Your session is about to expire
← Back to Search
Botulinum Toxin for Scarring
Study Summary
This trial will test whether a new medication can reduce scarring compared to using no medication. The study will use two biopsy sites on each person, so that each person serves as their own control. The study hypothesis is that the new medication will lead to less scarring.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I possibly qualify to join this clinical trial?
"The study team is looking for 12 individuals, aged 18 to 70, who currently have hypertrophy to participate. Additionally, all potential patients must meet the following: Be a healthy individual age 18 or older, Understand the requirements of the study and its associated risks, Be able to complete and sign a consent form."
Does this experiment only include those who are 50 and over?
"Patients that fall between 18-70 years old are eligible for this study. If a patient is too young (under 18) or too old (over 65), there are 10 and 49 other trials respectively that they may be able to enroll in."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger